Sold under the brands, Wegovy and Mounjaro, as well as the off-label prescriptions of the diabetes drug Ozempic, many hope ...

Weight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order ...

Just 800 of the 13,500 patients eligible to start receiving Wegovy, which can help obese people lose 15% of their body weight ...

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

ONE million people will buy weight-loss jabs next year, experts claim. The wonder drugs’ popularity has exploded on the back of celebrity trends and blockbuster clinical trials. Industry insiders ...

Doctors have said access to the drug is a "postcode lottery" as Sky News analysis reveals just 800 people have been ...

An online store has jumped on the Ozempic craze by releasing a “sexy” semaglutide injection costume just in time for ...

However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies are pursuing other approaches that could be even more effective or ...

I don’t normally pay much attention to the world of high fashion, but the controversy sparked by last month’s Paris fashion ...

L.A. is particularly susceptible to “miracle” cures. And there are some troubling aspects of the Ozempic gold rush that don’t ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.